Raymond James & Associates’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$215K Sell
7,550
-483
-6% -$13.8K ﹤0.01% 3603
2024
Q2
$232K Buy
+8,033
New +$226K ﹤0.01% 3521

Other funds holding AMJB

Raymond James & Associates's AMJB Position: Q3 2024 in Review

Raymond James & Associates reduced its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 6% in Q3 2024, selling an estimated $13.8K and leaving 7,550 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.

Raymond James & Associates first reported a position in AMJB in Q2 2024 and has held it in 2 quarters since. The position peaked at $232K in Q2 2024. 60 funds tracked by Wall St. Rank hold AMJB as of Q3 2024.

  • Raymond James & Associates held 7,550 shares of Alerian MLP Index ETNs due January 28 2044 worth $215K as of Q3 2024.
  • Raymond James & Associates sold 483 Alerian MLP Index ETNs due January 28 2044 shares in Q3 2024, an estimated $13.8K.
  • Alerian MLP Index ETNs due January 28 2044 made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3603 holding.
  • Raymond James & Associates first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q2 2024 and has held it in 2 quarters since.
  • Raymond James & Associates's Alerian MLP Index ETNs due January 28 2044 position peaked at $232K in Q2 2024.
  • 60 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.